A South Windsor company is now bringing on new meaning to the term face-lift.
Oxford Performance Materials, Inc., a 3-D printing company, has received clearance from the FDA for its 3-D printed OsteoFab® Patient-Specific Facial Device (OPSFD) for facial reconstruction. This follows FDA clearance of the first and only 3-D printed polymeric cranial implants, which was granted in February 2013.
"There has been a substantial unmet need in personalized medicine for truly individualized--yet economical--solutions for facial reconstruction, and the FDA’s clearance of OPM’s latest orthopedic implant marks a new era in the standard of care for facial reconstruction,” said Scott DeFelice, CEO and chairman of Oxford Performance Materials. “Until now, a technology did not exist that could treat the highly complex anatomy of these demanding cases. With the clearance of our 3-D printed facial device, we now have the ability to treat these extremely complex cases in a highly effective and economical way, printing patient-specific maxillofacial implants from individualized MRI or CT digital image files from the surgeon. This is a classic example of a paradigm shift in which technology advances to meet both the patient’s needs and the cost realities of the overall healthcare system.”
OPM technology is also designed to reduce the overall “cost of ownership” to the customer by decreasing operating room time, hospital length of stay and procedure complications. In addition, OsteoFab customers do not pay a premium for the individualized 3-D printed implant.
Next on the FDA’s approval list of implants are spinal and diabetic foot solutions.
The company uses the same 3-D printers to fabricate parts for the aerospace industry to replace heavier, less durable, aluminum parts.
This report filed last year takes a closer look at 3-D printing in South Windsor.